Low-Dose Aripiprazole is a Promising Drug for Long COVID Treatment: A Retrospective Observational Study

Authors
Category Primary study
ConferenceAnnual Meeting of the Infectious Diseases Society of America, ID Week 2025
Year 2026
This article has no abstract
Epistemonikos ID: 8a690d4eb99407388ecef1f5d0aee2b653acb9ae
First added on: Mar 17, 2026